Exactech Announces Investor Presentation at Canaccord Genuity Growth Conference
August 06 2013 - 11:00AM
Business Wire
Exactech, Inc. (Nasdaq: EXAC), a developer and producer of bone
and joint restoration products for hip, knee, shoulder, spine and
biologic materials, will update investors at the Canaccord Genuity
Growth Conference in Boston on Wednesday, August 14, 2013.
The presentation by Exactech president David Petty and CFO Jody
Phillips will begin at 10:30 a.m. ET on Wednesday, August 14,
followed by a question and answer session. The company will also
host one-on-one meetings with investors during the conference.
Exactech’s investor presentation including updates from the
second quarter 2013 will be available via live and archived webcast
at http://wsw.com/webcast/canaccord10/EXAC/ and at
http://www.hawkassociates.com/profile/exac.cfm
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Feb 2024 to Mar 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Mar 2023 to Mar 2024